Combined treatment with Metformin and 2-deoxy glucose induces detachment of viable MDA-MB-231 breast cancer cells in vitro

Abstract Triple naegative breast cancer has an increased rate of distant metastasis and consequently poor prognosis. To metastasize, breast cancer cells must detach from the main tumour mass and resist anoikis, a programmed cell death induced by lack of cell-extracellular matrix communication. Altho...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Maruša Bizjak, Petra Malavašič, Klemen Dolinar, Jelka Pohar, Sergej Pirkmajer, Mojca Pavlin
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/cc1ebdb8ba0041c29ba1283a03236ac4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cc1ebdb8ba0041c29ba1283a03236ac4
record_format dspace
spelling oai:doaj.org-article:cc1ebdb8ba0041c29ba1283a03236ac42021-12-02T12:32:44ZCombined treatment with Metformin and 2-deoxy glucose induces detachment of viable MDA-MB-231 breast cancer cells in vitro10.1038/s41598-017-01801-52045-2322https://doaj.org/article/cc1ebdb8ba0041c29ba1283a03236ac42017-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-01801-5https://doaj.org/toc/2045-2322Abstract Triple naegative breast cancer has an increased rate of distant metastasis and consequently poor prognosis. To metastasize, breast cancer cells must detach from the main tumour mass and resist anoikis, a programmed cell death induced by lack of cell-extracellular matrix communication. Although cancer cells must detach to metastasize in vivo, the viability of floating cancer cells in vitro is rarely investigated. Here we show that co-treatment of anoikis-resistant MDA-MB-231 cells with metformin and 2-deoxy-D-glucose (2-DG) increased the percentage of floating cells, of which about 95% were viable. Floating cells resumed their proliferation once they were reseeded in the pharmacological compound-free medium. Similar effects on detachment were observed on anoikis-prone MCF-7 cells. Co-treatment of MDA-MB-231 cells with metformin and 2-DG induced a strong activation of AMP-activated protein kinase (AMPK), which was reduced by AMPK inhibitor compound C that prevented detachment of MDA-MB-231 cells. However, direct AMPK activators A-769662 and AICAR did not have any major effect on the percentage of floating MDA-MB-231 cells, indicating that AMPK activation is necessary but not sufficient for triggering detachment of cancer cells. Our results demonstrate that separate analysis of floating and attached cancer cells might be important for evaluation of anti-cancer agents.Maruša BizjakPetra MalavašičKlemen DolinarJelka PoharSergej PirkmajerMojca PavlinNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-14 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Maruša Bizjak
Petra Malavašič
Klemen Dolinar
Jelka Pohar
Sergej Pirkmajer
Mojca Pavlin
Combined treatment with Metformin and 2-deoxy glucose induces detachment of viable MDA-MB-231 breast cancer cells in vitro
description Abstract Triple naegative breast cancer has an increased rate of distant metastasis and consequently poor prognosis. To metastasize, breast cancer cells must detach from the main tumour mass and resist anoikis, a programmed cell death induced by lack of cell-extracellular matrix communication. Although cancer cells must detach to metastasize in vivo, the viability of floating cancer cells in vitro is rarely investigated. Here we show that co-treatment of anoikis-resistant MDA-MB-231 cells with metformin and 2-deoxy-D-glucose (2-DG) increased the percentage of floating cells, of which about 95% were viable. Floating cells resumed their proliferation once they were reseeded in the pharmacological compound-free medium. Similar effects on detachment were observed on anoikis-prone MCF-7 cells. Co-treatment of MDA-MB-231 cells with metformin and 2-DG induced a strong activation of AMP-activated protein kinase (AMPK), which was reduced by AMPK inhibitor compound C that prevented detachment of MDA-MB-231 cells. However, direct AMPK activators A-769662 and AICAR did not have any major effect on the percentage of floating MDA-MB-231 cells, indicating that AMPK activation is necessary but not sufficient for triggering detachment of cancer cells. Our results demonstrate that separate analysis of floating and attached cancer cells might be important for evaluation of anti-cancer agents.
format article
author Maruša Bizjak
Petra Malavašič
Klemen Dolinar
Jelka Pohar
Sergej Pirkmajer
Mojca Pavlin
author_facet Maruša Bizjak
Petra Malavašič
Klemen Dolinar
Jelka Pohar
Sergej Pirkmajer
Mojca Pavlin
author_sort Maruša Bizjak
title Combined treatment with Metformin and 2-deoxy glucose induces detachment of viable MDA-MB-231 breast cancer cells in vitro
title_short Combined treatment with Metformin and 2-deoxy glucose induces detachment of viable MDA-MB-231 breast cancer cells in vitro
title_full Combined treatment with Metformin and 2-deoxy glucose induces detachment of viable MDA-MB-231 breast cancer cells in vitro
title_fullStr Combined treatment with Metformin and 2-deoxy glucose induces detachment of viable MDA-MB-231 breast cancer cells in vitro
title_full_unstemmed Combined treatment with Metformin and 2-deoxy glucose induces detachment of viable MDA-MB-231 breast cancer cells in vitro
title_sort combined treatment with metformin and 2-deoxy glucose induces detachment of viable mda-mb-231 breast cancer cells in vitro
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/cc1ebdb8ba0041c29ba1283a03236ac4
work_keys_str_mv AT marusabizjak combinedtreatmentwithmetforminand2deoxyglucoseinducesdetachmentofviablemdamb231breastcancercellsinvitro
AT petramalavasic combinedtreatmentwithmetforminand2deoxyglucoseinducesdetachmentofviablemdamb231breastcancercellsinvitro
AT klemendolinar combinedtreatmentwithmetforminand2deoxyglucoseinducesdetachmentofviablemdamb231breastcancercellsinvitro
AT jelkapohar combinedtreatmentwithmetforminand2deoxyglucoseinducesdetachmentofviablemdamb231breastcancercellsinvitro
AT sergejpirkmajer combinedtreatmentwithmetforminand2deoxyglucoseinducesdetachmentofviablemdamb231breastcancercellsinvitro
AT mojcapavlin combinedtreatmentwithmetforminand2deoxyglucoseinducesdetachmentofviablemdamb231breastcancercellsinvitro
_version_ 1718394006000369664